International Congress on Targeted Anticancer Therapies (TAT 2013)
March 4 - 6, 2013 (Not final)
Paris, France
The International Congress on Targeted Anticancer Therapies (TAT) is dedicated to targeted agents for the treatment of cancer and includes topics such as:
- Clinical development on approved targeted agents for cancer therapy
- Agents with a cancer-specific molecular target with a focus on early-phase clinical development agents
- Methodological and regulatory issues in anticancer drug development
- Early-phase clinical trials and translational research
The International Congress on Targeted Anticancer Therapies (TAT) brings together delegates from industry, academia and governmental agencies with an interest in the development of innovative cancer therapies.
Venue
Not final
Address
Paris,
France
France
Prices *
300-750 Euro
Exhibition
Included
Organization
NDDO Education Foundation, MCCM Meeting Management
Website
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Past and Future Events
Articles/News/Press releases
- Science conferences- learn for a better understanding of Science
- Determine the prevalence of hypermetropia among young male and female
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Mechanisms of hearing loss in prematures and fullterms with perinatal or postnatal hypoxia
- Cochlear Implantation in Auditory Neuropathy
- Chronic lymphocytic leukemia and related disorders - Clinical
